$PMCB's Institutional Stock Ownership and Shareholders ~ https://fintel.io/so/us/pmcb
PharmaCyte Biotech, Inc. has 4 institutional investors and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 2,054,073 shares. Largest shareholders include Panagora Asset Management Inc, Fisher Asset Management, LLC, Adell Harriman & Carpenter Inc, and Moloney Securities Asset Management, LLC.
PharmaCyte Biotech, Inc. ownership summary shows current positions in the company by institutions and funds, as well as latest changes in position size. Major shareholders can include individual investors, mutual funds, hedge funds, or institutions. The Schedule 13D indicates that the investor holds more than 5% of the company and intends to actively pursue a change in business strategy. Schedule 13G indicates a passive investment of over 5%.
PharmaCyte Biotech, Inc. has 4 institutional investors and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 2,054,073 shares. Largest shareholders include Panagora Asset Management Inc, Fisher Asset Management, LLC, Adell Harriman & Carpenter Inc, and Moloney Securities Asset Management, LLC.
PharmaCyte Biotech, Inc. ownership summary shows current positions in the company by institutions and funds, as well as latest changes in position size. Major shareholders can include individual investors, mutual funds, hedge funds, or institutions. The Schedule 13D indicates that the investor holds more than 5% of the company and intends to actively pursue a change in business strategy. Schedule 13G indicates a passive investment of over 5%.
